As Director of Marketing for Healthcare Services & Solutions (HSS), a wholly-owned entity of Merck, Glenn leads customer engagement to better understand the intersection between demand in infectious diseases and the application of health information technology. Glenn joined HSS in 2014, and current responsibilities include leading engagement initiatives for ILÚM Health Solutions, an HSS company that leverages data within existing health IT systems to support hospital goals for improved outcomes for ID patients.

In addition, Glenn previously held leadership positions in Merck’s Global Human Health Division. Beginning in 2008, he had global responsibility for Merck’s Antibiotic portfolio, focusing on antimicrobial stewardship and enhancing scientific collaboration and access in emerging markets. In this role, Glenn led worldwide marketing and management of the Study for Monitoring Antimicrobial Resistance Trends (SMART), currently one of the largest ongoing epidemiology studies of tracking resistance. This global perspective, particularly throughout Asia-Pacific, provided Glenn a unique skill set and perspective when he transitioned to the US Anti-Infective franchise. Here, he led the development and implementation of an integrated strategy for Merck’s antibiotic and antifungal portfolio.

Glenn holds an MBA from Villanova University and a BS in Health Sciences from James Madison University.

Personally as well as professionally, Glenn values the principles of teamwork and commitment that he learned as a Division I Scholar Athlete in baseball. He shares those values not only in his work, but also as a youth sports coach.